Abstract
Mechanisms involved in induction processes have been investigated using fresh human hepatocytes in culture as a cellular model and using mass spectrometry-based metabonomics as a global investigation tool. Sample preparation to data analysis have been detailed in an approach enabling to separate drug-induced (endogenous metabolites) and drug-related (drug metabolites) biomarkers for reference inducers. Rifampicin, a nuclear pregnane X receptor (PXR) ligand; CITCO, a nuclear constitutive androstane receptor (CAR) ligand; and phenobarbital, which activates both CAR and PXR, have been used. Specific intra-cellular metabolites have been isolated for rifampicin and CITCO as potential endogenous biomarkers of their respective induction mechanism. A mixture of these two types of biomarkers modified in the same way after treatment with either rifampicin or CITCO on the one hand and with phenobarbital on the other hand has been found.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Parmentier, Y., Bossant, M.-J., Bertrand, M., and Walther, B. (2007) In vitro studies of drug metabolism, Comprehensive Medicinal Chemistry II (Taylor, J.B. and Triggle, D.J. eds.), Elsevier, Amsterdam Netherland, pp. 231–257.
Handschin, C. and Meyer, U.A. (2003) Induction of drug metabolism: the role of nuclear receptors. Pharmacol. Rev. 55, 649–673.
Luo, G., Guenthner, T., Gan, L.S., and Humphreys, W.G. (2004) CYP3A4 induction by xenobiotics: biochemistry, experimental methods and impact on drug discovery and development. Curr. Drug Metab. 5, 483–505.
Tompkins, L.M. and Wallace, A.D. (2007) Mechanisms of cytochrome P450 induction. J. Biochem. Mol. Toxicol. 21, 176–181.
Konno, Y., Negishi, M., and Kodama, S. (2008) The roles of nuclear receptors CAR and PXR in hepatic energy metabolism. Drug. Metab. Pharmacokinet. 23, 8–13.
Maglich, J.M., Parks, D.J., Moore, L.B., Collins, J.L., Goodwin, B., Billin, A.N., Stoltz, C.A., Kliewer, S.A., Lambert, M.H., Willson, T.M., and Moore, J.T. (2003) Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes. J. Biol. Chem. 278, 17277–17283.
Sueyoshi, T. and Negishi, M. (2001) Phenobarbital response elements of cytochrome P450 genes and nuclear receptors. Annu. Rev. Pharmacol. Toxicol. 41, 123–143.
Orans, J., Teotico, D.G., and Redinbo, M. (2005) The nuclear xenobiotic receptor pregnane X receptor: recent insights and new challenges. Mol. Endocrinol. 19, 2891–2900.
Pascussi, J.-M., Gerbal-Chaloin, S., Duret, C., Daujat-Chavanieu, M., Vilarem, M. J., and Maurel, P. (2008) The tangle of nuclear receptors that controls xenobiotic metabolism and transport: crosstalk and consequences. Annu. Rev. Pharmacol. Toxicol. 48, 1–32.
Moreau, A., Vilarem, M.J., Maurel, P., and Pascussi, J.-M. (2008) Xenoreceptors CAR and PXR activation and consequences on lipid metabolism, glucose homeostasis, and inflammatory response. Mol. Pharm. 5, 35–41.
Nicholson, J.K., Lindon, J.C., and Holmes, E. (1999) ‘Metabonomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29, 1181–1189.
Bren, L. (2005) Metabolomics: working toward personalized medicine. FDA Consumer Magazine (November–December Issue) 39(6), 28–33.
Lindon, J.C., Holmes, E., and Nicolson, J.K. (2007) Metabonomics in pharmaceutical R&D. FEBS J. 274, 1140–1151.
Khoo, S.H. and Al-Rubeai, M. (2007) Metabolomics as a complementary tool in cell culture. Biotechnol. Appl. Biochem. 47, 71–84.
Isom, H.C. and Georgoff, I. (1984) Quantitative assay for albumin-producing liver cells after simian virus 40 transformation of rat hepatocytes maintained in chemically defined medium. PNAS 81, 6378–6382.
Brindle, J.T., Antti, H., Holmes, E., Tranter, G., Nicholson, J.K., Bethell, H.W., Clarke, S., Schofield, P.M., McKilligin, E., Mosedale, D.E., and Grainger, D.J. (2002) Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat. Med. 8, 1439–1444.
Coen, M., Holmes, E., Lindon, J.C., and Nicholson J.K. (2008) NMR-based metabolic profiling and metabonomic approaches to problems in molecular toxicology. Chem. Res. Toxicol. 21, 9–27.
Gavaghan, C.L., Holmes, E., Lenz, E., Wilson, I.D., and Nicholson, J.K. (2000) An NMR-based metabonomic approach to investigate the biochemical consequences of genetic strain differences: application to the C57BL10J and Alpk:ApfCD mouse. FEBS Lett. 484, 169–174.
Fiehn, O., Kopka, J., Trethewey, R.N., and Willmitzer, L. (2000) Identification of uncommon plant metabolites based on calculation of elemental compositions using gas chromatography and quadrupole mass spectrometry. Anal. Chem. 72, 3573–3580.
O’Hagan, S., Dunn, W.B., Brown, M., Knowles, J.D., and Kell, D.B. (2005) Closed-loop, multiobjective optimization of analytical instrumentation: gas chromatography/time-of-flight mass spectrometry of the metabolomes of human serum and of yeast fermentations. Anal. Chem. 77, 290–303.
Shellie, R.A., Welthagen, W., Zrostlikova, J., Spranger, J., Ristow, M., Fiehn, O., and Zimmermann, R. (2005) Statistical methods for comparing comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry results: metabolomic analysis of mouse tissue extracts. J. Chromatogr. A 1086, 83–90.
Wilson, I.D., Nicholson, J.K., Castro-Perez, J., Granger, J.H., Johnson, K.A., Smith, B.W., and Plumb, R.S. (2005) High resolution “ultra performance” liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies. J. Proteome Res. 4, 591–598.
Plumb, R.S., Rainville, P., Smith, B.W., Johnson, K.A., Castro-Perez, J., Wilson, I.D., and Nicholson, J.K. (2006) Generation of ultrahigh peak capacity LC separations via elevated temperatures and high linear mobile-phase velocities. Anal. Chem. 78, 7278–7283.
Want, E.J., Nordström, A., Morita, H., and Siuzdak, G. (2007) From exogenous to endogenous: the inevitable imprint of mass spectrometry in metabolomics. J. Proteome Res. 6, 459–468.
Wiklund, S., Johansson, E., Sjöström, L., Mellerowicz, E.J., Edlund, U., Shockcor, J.P., Gottfries, J., Moritz, T., and Trygg, J. (2008) Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. Anal. Chem. 80, 115–122.
Pichard, L., Raulet, E., Fabre, G., Ferrini, J.B., Ourlin, J.C., and Maurel, P. (2006) Human hepatocyte culture. Methods Mol. Biol. 320, 283–293.
Katajamaa, M. and Oresic, M. (2007) Data processing for mass spectrometry-based metabolomics. J. Chromatogr. A 1158, 318–328.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Croixmarie, V. et al. (2010). Metabonomic Studies on Human Hepatocyte in Primary Culture. In: Maurel, P. (eds) Hepatocytes. Methods in Molecular Biology, vol 640. Humana Press. https://doi.org/10.1007/978-1-60761-688-7_19
Download citation
DOI: https://doi.org/10.1007/978-1-60761-688-7_19
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60761-687-0
Online ISBN: 978-1-60761-688-7
eBook Packages: Springer Protocols